Insider filing · SPRY

James E Flynn sold $13.7M of ARS Pharmaceuticals (SPRY)

Executed Jun 27 2025, disclosed Jul 1 2025, 4 days later.

Returns are measured on stock purchases only.

JF James E Flynn Director profile →

James E Flynn (Director) filed 2 Form 4 reports in the trailing twelve months (1 purchase, 1 sale), most often in Larimar Therapeutics, Inc. (LRMR). Across 1 priced purchase filing, the average 21-session return was -16.6% from execution and -14.2% from disclosure (delay-adjusted; derived). The largest single filing was $70.9M of NUVL (742,574 sh across 2 lots, as filed), executed Nov 24 2025.

SPRY SPRY SPRY · 38 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→